Background. The invasive disease potential (IDP) of Streptococcus pneumoniae differs between serotypes, but the reason for this is unknown. Methods. A total of 47 pneumococcal isolates from 13 serotypes with different IDPs in humans that belonged to 37 multilocus sequence types were compared by whole genome microarrays and mutant analyses. Results. Approximately 34% of the genes were variable, including 95 genes previously shown by signature-tagged mutagenesis (STM) to be required for invasive disease in mice. Many variable genes were localized to 41 accessory regions (ARs), of which 24 contained genes previously identified by STM as required for invasive disease. Only AR6 and AR34 were preferentially found in isolates of serotypes with hig...
The population structure of Streptococcus pneumoniae in a sample of 134 carried antibiotic-susceptib...
The isolation of Streptococcus pneumoniae serotypes in systemic tissues of patients with invasive di...
Funder: Joint Programming Initiative on Antimicrobial Resistance; doi: http://dx.doi.org/10.13039/10...
(See the editorial commentary by Klugman et al on pages 321–2.) Background. Pneumococcal serotypes a...
The bacterial factors responsible for the variation in invasive potential between different clones a...
Background: Streptococcus pneumoniae continues to cause morbidity and mortality across the globe, wi...
Streptococcus pneumoniae (the pneumococcus) is one of the most significant causes of human mortality...
p>Streptococcus pneumoniae is a human pathogen and a major contributor to morbidity and mortality wo...
BACKGROUND: Understanding genetic determinants of a microbial phenotype generally involves creating ...
Streptococcus pneumoniae is a Gram-positive bacterium that can cause a wide range of diseases. These...
By use of multilocus sequence typing, Streptococcus pneumoniae isolates causing invasive disease (n=...
Streptococcus pneumoniae is a gram-positive bacterium that can be found in both healthy carriers as ...
Streptococcus pneumoniae is the leading infectious cause of death in children in the world. However,...
Extent: 14p.The bacterial factors responsible for the variation in invasive potential between differ...
The population structure of Streptococcus pneumoniae in a sample of 134 carried antibiotic-susceptib...
The population structure of Streptococcus pneumoniae in a sample of 134 carried antibiotic-susceptib...
The isolation of Streptococcus pneumoniae serotypes in systemic tissues of patients with invasive di...
Funder: Joint Programming Initiative on Antimicrobial Resistance; doi: http://dx.doi.org/10.13039/10...
(See the editorial commentary by Klugman et al on pages 321–2.) Background. Pneumococcal serotypes a...
The bacterial factors responsible for the variation in invasive potential between different clones a...
Background: Streptococcus pneumoniae continues to cause morbidity and mortality across the globe, wi...
Streptococcus pneumoniae (the pneumococcus) is one of the most significant causes of human mortality...
p>Streptococcus pneumoniae is a human pathogen and a major contributor to morbidity and mortality wo...
BACKGROUND: Understanding genetic determinants of a microbial phenotype generally involves creating ...
Streptococcus pneumoniae is a Gram-positive bacterium that can cause a wide range of diseases. These...
By use of multilocus sequence typing, Streptococcus pneumoniae isolates causing invasive disease (n=...
Streptococcus pneumoniae is a gram-positive bacterium that can be found in both healthy carriers as ...
Streptococcus pneumoniae is the leading infectious cause of death in children in the world. However,...
Extent: 14p.The bacterial factors responsible for the variation in invasive potential between differ...
The population structure of Streptococcus pneumoniae in a sample of 134 carried antibiotic-susceptib...
The population structure of Streptococcus pneumoniae in a sample of 134 carried antibiotic-susceptib...
The isolation of Streptococcus pneumoniae serotypes in systemic tissues of patients with invasive di...
Funder: Joint Programming Initiative on Antimicrobial Resistance; doi: http://dx.doi.org/10.13039/10...